SCHEMBL16995353

SCHEMBL16995353

CCCN(CCNC=O)CCC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 3/20 0.43
ADH1A P07327 3/20 0.43
ADH7 P40394 3/20 0.43
ADH1C P00326 2/20 0.41
EPHX1 P07099 1/20 0.39
ADH4 P08319 1/20 0.39
KDM5A P29375 7/20 0.39
KDM4C Q9H3R0 5/20 0.38
PHF8 Q9UPP1 2/20 0.37
FFAR3 O14843 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
EPHX2 P34913 7/20 0.35
KDM5C P41229 1/20 0.35
KDM5B Q9UGL1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16995352 0.91 ADH1B (0.36) ADH1BADH1AADH7ADH1CEPHX1
SCHEMBL9726709 0.87 ADH1B (0.56) ADH1BADH1AADH7ADH1CEPHX1
SCHEMBL16995385 0.86 ADH1B (0.43) ADH1BADH1AADH7ADH1CEPHX1
SCHEMBL18938102 0.84 CAMK2A (0.32) ADH1BADH1AADH7KDM5AKDM4C
SCHEMBL3199687 0.82 FFAR3 (0.52) KDM5AKDM4CPHF8FFAR3HDAC3
SCHEMBL9621247 0.82 FFAR3 (0.52) KDM5AKDM4CPHF8FFAR3HDAC3
SCHEMBL8194762 0.80 FFAR3 (0.50) KDM5AKDM4CPHF8FFAR3HDAC3
Ammonia Solution, Strong SCHEMBL28145013 0.80 FFAR3 (0.50) KDM5AKDM4CPHF8FFAR3HDAC3
SCHEMBL11585196 0.80 FFAR3 (0.50) KDM5AKDM4CPHF8FFAR3HDAC3
SCHEMBL28143872 0.80 FFAR3 (0.50) KDM5AKDM4CPHF8FFAR3HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576586-B1 C-28 AMIDES OF MODIFIED C-3 BETULINIC ACID DERIVATIVES AS HIV MATURATION INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2015-08-12 EP disclosed